These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10026781)

  • 21. [Inhibition of protein kinase C with calphostin increases the hydroosmotic effect of vasopressin].
    Natochin IuV; Shakhmatova EI
    Dokl Akad Nauk; 1993 Dec; 333(6):805-6. PubMed ID: 7509227
    [No Abstract]   [Full Text] [Related]  

  • 22. [Peculiarities of signal transfer from arginine-vasopressin receptors located on the apical surface of the frog bladder epithelium and ameba outer membrane].
    Bagrov IaIu; Manusova NB
    Zh Evol Biokhim Fiziol; 2005; 41(6):562-5. PubMed ID: 16396474
    [No Abstract]   [Full Text] [Related]  

  • 23. De Wied and colleagues IV: research into mechanisms of action by which vasopressin and oxytocin influence memory processing.
    McEwen BB
    Adv Pharmacol; 2004; 50():177-225, 655-708. PubMed ID: 15350261
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasopressin antagonists.
    Berl T
    N Engl J Med; 2015 Jun; 372(23):2207-16. PubMed ID: 26039601
    [No Abstract]   [Full Text] [Related]  

  • 25. General introduction to vasopressin and oxytocin: structure/metabolism, evolutionary aspects, neural pathway/receptor distribution, and functional aspects relevant to memory processing.
    McEwen BB
    Adv Pharmacol; 2004; 50():1-50, 655-708. PubMed ID: 15350257
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic changes in waking rats with acute streptozotocin diabetes after administration of the combined V2/V1 vasopressin antagonist].
    Kuznetsova LV; Medvedeva NA; Medvedev OS
    Biull Eksp Biol Med; 1993 Jun; 115(6):594-6. PubMed ID: 8374133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasopressin antagonists].
    de Groote P
    Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):59-61. PubMed ID: 11933560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy?
    Filippatos G; Parissis JT
    J Card Fail; 2008 Oct; 14(8):648-50. PubMed ID: 18926435
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of epithelial sodium channel densities by vasopressin signalling.
    Els WJ; Helman SI
    Cell Signal; 1989; 1(6):533-9. PubMed ID: 2561947
    [No Abstract]   [Full Text] [Related]  

  • 30. The mechanisms of action of antidiuretic hormone.
    Jard S; Butlen D; Cantau B; Guillon G; Marie J; Roy C
    Adv Nephrol Necker Hosp; 1984; 13():163-77. PubMed ID: 6089519
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasopressin and pair-bond formation: genes to brain to behavior.
    Nair HP; Young LJ
    Physiology (Bethesda); 2006 Apr; 21():146-52. PubMed ID: 16565480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia.
    Finley JJ; Konstam MA; Udelson JE
    Circulation; 2008 Jul; 118(4):410-21. PubMed ID: 18645067
    [No Abstract]   [Full Text] [Related]  

  • 33. Vasopressin antagonists: present and future.
    Hofbauer KG; Mah SC
    Kidney Int Suppl; 1987 Aug; 21():S76-82. PubMed ID: 3306108
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vasopressin as a vasoactive agent: Its intracellular signal mechanism].
    Kozawa O
    Masui; 2008 Nov; 57 Suppl():S77-85. PubMed ID: 22462165
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview of cellular electrophysiological actions of vasopressin.
    Raggenbass M
    Eur J Pharmacol; 2008 Apr; 583(2-3):243-54. PubMed ID: 18280467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyponatremia in cirrhosis: from pathogenesis to treatment.
    Ginés P; Berl T; Bernardi M; Bichet DG; Hamon G; Jiménez W; Liard JF; Martin PY; Schrier RW
    Hepatology; 1998 Sep; 28(3):851-64. PubMed ID: 9731583
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antidiuretic hormone: not just a question of water].
    Fiaccadori E
    G Ital Nefrol; 2011; 28(5):468. PubMed ID: 22028255
    [No Abstract]   [Full Text] [Related]  

  • 38. Apelin counteracts vasopressin-induced water reabsorption via cross talk between apelin and vasopressin receptor signaling pathways in the rat collecting duct.
    Hus-Citharel A; Bodineau L; Frugière A; Joubert F; Bouby N; Llorens-Cortes C
    Endocrinology; 2014 Nov; 155(11):4483-93. PubMed ID: 25157454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells.
    Aoyagi T; Izumi Y; Hiroyama M; Matsuzaki T; Yasuoka Y; Sanbe A; Miyazaki H; Fujiwara Y; Nakayama Y; Kohda Y; Yamauchi J; Inoue T; Kawahara K; Saito H; Tomita K; Nonoguchi H; Tanoue A
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F100-7. PubMed ID: 18448596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Age-related changes in the molecular mechanisms of the hormonal regulation of kidney function].
    Ivanova LN; Zelenina MN; Logvinenko NS; Svitasheva NG; Solenov EI
    Zh Evol Biokhim Fiziol; 1990; 26(4):482-9. PubMed ID: 2175531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.